8-K: Gyrodyne Provides Update at 2024 Annual Meeting, Focuses on Property Sales and Shareholder Value

Gyrodyne's management provided an update at the 2024 Annual Meeting, highlighting progress on property sales, legal challenges, and financial performance amidst economic headwinds.

Summary

• Gyrodyne held its 2024 Annual Shareholders Meeting on October 7, 2024, where management discussed the company's progress and challenges.
• The company's primary goal remains selling properties at post-entitled values and making liquidating distributions to shareholders as soon as possible.
• A Rights Offering completed since the last annual meeting was over 65% oversubscribed, generating approximately $4.4 million in net proceeds.
• Gyrodyne has retained JLL Capital Markets to market its Flowerfield and Cortlandt Manor properties, hoping to announce transactions soon.
• The Cortlandt Manor property has received entitlements for up to 150,000 square feet of medical office and 4,000 square feet of retail use.
• A court decision regarding the Article 78 proceeding challenging the Flowerfield property division was partially denied and partially granted, with further briefs submitted.
• For the first six months of 2024, costs in excess of operating receipts were approximately $575,000, a reduction of approximately $580,000 compared to the same period in 2023.
• The company's occupancy rate was 82% as of June 2024, down from 85% in December 2022.
• The estimated liquidating value per share decreased from $17.45 in December 2022 to $16.09 as of the second quarter 2024.
• Total NAV increased by approximately $5 million between year-end 2022 and June 2024, mainly due to the Rights Offering proceeds.
• The company has locked in three term loans at fixed rates ranging from 3.75% to 3.85% with maturity dates in 2027 and 2028, with a total principal of $11.3 million outstanding as of June 30, 2024.
• The annual debt service is approximately $1 million, contributing to a forecasted annual burn rate of $1.3 million, excluding land development and Article 78 related litigation expenses.
• Gyrodyne is hopeful to receive final entitlements on Flowerfield in late 2024 and is actively marketing both Flowerfield and Cortlandt Manor properties.
• The company remains open to offers for the properties as is, or for the sale of the company itself.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with some positive developments like the oversubscribed rights offering and cost reductions, but also negative aspects such as the decrease in NAV per share and occupancy rate, along with ongoing legal challenges and economic headwinds. The sentiment is neutral to slightly negative.

Positives

• The Rights Offering was oversubscribed, indicating investor confidence and providing $4.4 million in net proceeds.
• The engagement of JLL Capital Markets is expected to enhance the sales process for the properties.
• The Cortlandt Manor property has secured entitlements, increasing its marketability.
• Operating costs have been reduced by approximately $580,000 in the first half of 2024 compared to the same period in 2023.
• Total NAV increased by approximately $5 million between year-end 2022 and June 2024.
• The company has locked in fixed-rate debt, mitigating the impact of rising interest rates.

Negatives

• The estimated liquidating value per share decreased from $17.45 in December 2022 to $16.09 as of the second quarter 2024.
• The occupancy rate has decreased from 85% in December 2022 to 82% as of June 2024.
• The company faces challenges in increasing occupancy rates and average rates per square foot due to market conditions.
• The Article 78 proceeding is ongoing and creates uncertainty.
• The company is facing economic headwinds including higher interest rates and inflation.

Risks

• The success of property sales is contingent on obtaining final entitlements, which is subject to local officials' decisions.
• The market for medical office properties has changed significantly following the pandemic, creating challenges.
• Economic headwinds, including higher interest rates and inflation, pose risks to the company's operations and development opportunities.
• The ongoing Article 78 proceeding creates uncertainty and potential costs.
• The company's ability to increase occupancy rates and average rates per square foot is challenged by market conditions.

Future Outlook

Gyrodyne is hopeful to receive final entitlements on Flowerfield in late 2024 and is actively marketing both Flowerfield and Cortlandt Manor properties with the goal of entering into sales agreements at post entitled values. The company remains open to offers for the properties as is, or for the sale of the company itself.

Management Comments

• Our stated goals remain unchanged sell the properties at post entitled values and make liquidating distributions as soon as possible.
• We made significant corporate governance and compensation enhancements including the addition of Jan Loeb as a director.
• We are hopeful we will receive final entitlements on Flowerfield in late 2024.
• We remain open to offers for the properties as is and where is and or for sale of the Company itself.

Industry Context

The announcement reflects the challenges faced by the commercial office market, particularly in the wake of the pandemic, with increased interest rates and inflation impacting development opportunities. The company's focus on medical office space aligns with a growing trend in the real estate sector, but the market is still facing headwinds.

Comparison to Industry Standards

• The decrease in occupancy rate from 85% to 82% is indicative of the broader challenges faced by commercial office properties, with many companies experiencing similar declines.
• The company's focus on obtaining entitlements to increase property value is a common strategy in real estate development, similar to other companies seeking to maximize returns on their assets.
• The use of JLL Capital Markets for property sales is a standard practice for companies seeking to reach a wide range of potential buyers, similar to other companies in the sector.
• The company's fixed-rate debt strategy is a common approach to mitigate the impact of rising interest rates, similar to other companies seeking to manage their financial risks.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in an Article 78 proceeding challenging the Town of Smithtown's granting of preliminary approval to divide the Flowerfield property.
• The court has issued a decision regarding the motion for dismissal of the Article 78 proceeding, partially denying and partially granting the motions.
• The parties have submitted briefs on the merits of the remaining petitioners contentions and are awaiting the court's decision.

Stakeholder Impact

• Shareholders are impacted by the decrease in NAV per share and the ongoing legal challenges.
• Shareholders are expected to receive liquidating distributions upon the sale of properties.
• Employees are impacted by the company's cost reduction efforts.
• Potential buyers of the properties are impacted by the entitlement process and market conditions.

Next Steps

• Gyrodyne will continue to market the Flowerfield and Cortlandt Manor properties.
• The company will await the court's decision on the Article 78 proceeding.
• Gyrodyne will seek final entitlements for the Flowerfield property.
• The company will make prompt public disclosure of any definitive agreements reached.

Key Dates

Keywords

property sales, real estate, entitlements, liquidating distributions, rights offering, medical office, Article 78, NAV, occupancy rate, debt, JLL Capital Markets